Drug Discovery News
-
Mesoblast to develop neuro diseases therapies
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
Singapore: Australian company Mesoblast has outlined the company's strategic plans to develop adult stem cell therapies...Read more
-
BMS halts Hep C drug administration
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Aug, 2012
Singapore: Bristol-Myers Squibb (BMS) has suspended study drug administration in an ongoing phase II study of BMS-986094...Read more
-
Starpharma drug targets cancer more effectively
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2012
Singapore: Australia-based Starpharma reported significant tumor-targeting results with its proprietary dendrimer-doceta...Read more
-
Eisai, Toyama get marketing approval for iguratimod
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 02 Jul, 2012
Singapore: Eisai and Toyama Chemical have received approval from Japan's Ministry of Health, Labour and Welfare to marke...Read more
-
Jazz Pharma clocks $208 mn in Q2 2013
Drug Discovery | Company results | By BioSpectrum Bureau | 0 Comment | 07 Aug, 2013
Singapore: Jazz Pharmaceuticals reported earnings worth $208.3 million in revenue during the second quarter of 2013, an...Read more
-
Charles River to acquire Galapagos at USD 179 mn
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Mar, 2014
Singapore: Charles River Laboratories is soon to acquire CRO services division of Galapagos, which includes both Argenta...Read more
-
Chugai, Nippon Shinyaku tie up for drug development
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Dec, 2012
Singapore: Tokyo-headquartered Chugai Pharmaceutical and Kyotobased Nippon Shinyaku have entered into an agreement to co...Read more
-
EMA recommends MSD's melanoma drug
Drug Discovery | Regulatory | By BioSpectrum Bureau | 5 Comment | 27 May, 2015
Singapore: European Medicines Agency (EMA) has recommended granting a marketing authorization for Merck Sharp And Dohme'...Read more
-
10 top global pharma firms join hands for drug discovery
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 20 Sep, 2012
Singapore: Ten leading biopharmaceutical companies have formed a non-profit organization to accelerate the development ...Read more
-
Nuvilex, Lincoln Park Fund sign $27 mn stock deal
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Feb, 2014
Singapore: Nuvilex, an international biotechnology company providing cell and gene therapy solutions for the treatment o...Read more
-
Korea to spend $8.9 bn to develop 20 drugs by 2017
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2013
Singapore: South Korea will channelize a combined $8.9 billion (10 trillion Won) on developing 20 new drugs over the nex...Read more
-
Abbott reveals 10-year study data for HUMIRA
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Jun, 2012
Singapore: Abbott revealed the results from two long-term, open-label studies, which evaluated the results of HUMIRA (ad...Read more
-
Edinburgh Univ, Biogen to study neuro diseases
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2013
Singapore: Experts from University of Edinburgh, UK, and Massachusetts-based biotechnology company Biogen Idec have join...Read more
-
Admedus acquires Genzyme manufacturing site
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Dec, 2013
Singapore: Admedus, formerly Allied Healthcare, has signed a share purchase agreement to acquire an established manufact...Read more
-
AstraZeneca halts development of obesity drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Sep, 2012
Singapore: Palatin Technologies collaboration with AstraZeneca is to be discontinued for the further development of AZD2...Read more
-
Trajenta shows blood glucose improvements
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2012
Singapore: Results from a two-year study has demonstrated that Boehringer Ingelheim's Trajenta (linagliptin) provides si...Read more
-
Drug Discovery | Opinion | By Nandita Singh | 0 Comment | 01 Aug, 2012
VM202 is a DNA-based drug that is designed to produce two isoforms of hepatocyte growth factor (HGF) - HGF 728 and HGF ...Read more
-
China invests $160 bn in biomedicine sector
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Jul, 2013
Singapore: A report filed by Lux Research that tracks emerging technologies has said that China has invested a staggerin...Read more
